BGI Genomics Co., Ltd. (300676.SZ)
CNY 45.76
(-0.72%)
CNY 45.76
(-0.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 408.76 Million | 136.37 Million | 2.47 Billion | 3.6 Billion | 224.25 Million | 14.68 Million |
| Net Income | 93.68 Million | 809.44 Million | 1.47 Billion | 2.1 Billion | 278.51 Million | 407.84 Million |
| Depreciation & Amortization | 436.83 Million | 453.03 Million | 370.6 Million | 302.33 Million | 241.07 Million | 169.01 Million |
| Deferred income taxes | 24.93 Million | 10.36 Million | -34.51 Million | -85.2 Million | 17.42 Million | -20.64 Million |
| Stock-based compensation | 122.8 Million | - | - | 95.96 Million | - | - |
| Change in working capital | -479.67 Million | -1.48 Billion | 537.08 Million | 956.34 Million | -397.28 Million | -609.83 Million |
| Other non-cash items | 357.92 Million | 326.58 Million | 90.75 Million | 231.2 Million | 101.94 Million | 47.65 Million |
| Investing Cash Flow | -1.75 Billion | -583.57 Million | -2.29 Billion | 193.97 Million | -842.66 Million | 501.99 Million |
| Investments in PPE | -1.23 Billion | -1.26 Billion | -383.51 Million | -301.15 Million | -626.43 Million | -678.12 Million |
| Acquisitions | 2.71 Million | 1.14 Million | 5.9 Million | 4.03 Million | 1.3 Million | -31.83 Million |
| Investment purchases | -4.09 Billion | -2.56 Billion | -4.19 Billion | -3.93 Billion | -247.78 Million | -161.36 Million |
| Sales/Maturities of investments | 3.57 Billion | 3.23 Billion | 2.3 Billion | 4.43 Billion | 8.43 Million | 81.1 Million |
| Other Investing Activities | 6.39 Million | 5.1 Million | -19.63 Million | -2.18 Million | 21.82 Million | 1.29 Billion |
| Financing Cash Flow | -266.88 Million | -1.19 Billion | 1.03 Billion | 1.15 Billion | 348 Million | -488.16 Million |
| Debt repayment | -12 Million | -693.5 Million | -586.99 Million | -25.26 Million | -200.59 Million | -8 Million |
| Dividends payments | -413.91 Million | -143.46 Million | -144.86 Million | -40 Million | -40.01 Million | -200.32 Million |
| Common Stock Repurchased | - | -363.33 Million | -26.1 Million | -482.32 Million | -3.37 Million | - |
| Common Stock Issuance | 82.85 Million | 64.06 Million | 26.1 Million | 482.32 Million | -197.21 Million | - |
| Other Financing Activities | -89.82 Million | -34.64 Million | 1.8 Billion | 1.23 Billion | 789.19 Million | -279.84 Million |
| Accounts receivables | 736.48 Million | -1.05 Billion | 254.15 Million | -471.96 Million | -421.6 Million | -585.91 Million |
| Accounts payables | -1.34 Billion | -482.91 Million | 147.51 Million | 2.11 Billion | 107.96 Million | 102.47 Million |
| Inventory | 103.78 Million | 46.25 Million | 169.93 Million | -603.69 Million | -101.06 Million | -103.32 Million |
| Other working capital | -583.45 Million | 10.36 Million | -34.51 Million | -85.2 Million | 17.42 Million | -506.5 Million |
| Cash at beginning of period | 5.13 Billion | 6.49 Billion | 5.41 Billion | 725.48 Million | 990.67 Million | 946.45 Million |
| Cash at end of period | 3.55 Billion | 5.12 Billion | 6.49 Billion | 5.41 Billion | 725.48 Million | 990.67 Million |
| Capital Expenditure | -1.23 Billion | -1.26 Billion | -383.51 Million | -301.15 Million | -626.43 Million | -678.12 Million |
| Effect of forex changes on cash | 32.82 Million | 279.37 Million | -139.9 Million | -262.51 Million | 5.21 Million | 15.69 Million |
| Net cash flow / Change in cash | -1.57 Billion | -1.36 Billion | 1.08 Billion | 4.68 Billion | -265.18 Million | 44.22 Million |
| Free Cash Flow | -827.61 Million | -1.13 Billion | 2.09 Billion | 3.3 Billion | -402.18 Million | -663.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -142.36 Million | 5.79 Million | 12.4 Million | 22.54 Million | 93.68 Million | 18.6 Million |
| Depreciation & Amortization | - | 134.24 Million | 134.24 Million | 418.74 Million | 436.83 Million | -209.48 Million |
| Deferred income taxes | - | - | - | - | 24.93 Million | 718.33 Million |
| Stock-based compensation | - | - | - | 122.8 Million | 122.8 Million | -61.19 Million |
| Change in working capital | - | - | - | 963.07 Million | -479.67 Million | -479.16 Million |
| Other non-cash items | 116.91 Million | 155.14 Million | -80 Million | -1.3 Billion | 357.92 Million | 188.89 Million |
| Investing Cash Flow | -582.98 Million | 608.42 Million | -592.09 Million | -1.67 Billion | -1.75 Billion | -119.19 Million |
| Investments in PPE | -168.07 Million | -86.91 Million | -109.14 Million | -290.56 Million | -1.23 Billion | -423.33 Million |
| Acquisitions | 59.67 Thousand | 142.49 Thousand | 4.08 Million | 2.66 Million | 2.71 Million | 45.22 Thousand |
| Investment purchases | -4.46 Billion | -1.8 Billion | -1.55 Billion | -2.17 Billion | -4.09 Billion | -459.39 Million |
| Sales/Maturities of investments | 4.05 Billion | 2.49 Billion | 1.07 Billion | 782.89 Million | 3.57 Billion | 763.49 Million |
| Other Investing Activities | 59.67 Thousand | 142.49 Thousand | -474.6 Million | 6.57 Million | 6.39 Million | 0.91 |
| Financing Cash Flow | -19.1 Million | -300.37 Million | 2.66 Million | -52.88 Million | -266.88 Million | 61.77 Million |
| Debt repayment | -38.99 Million | -73.18 Million | -26.39 Million | -6 Million | -12 Million | -32.08 Million |
| Dividends payments | -43.95 Million | -1.92 Million | -1.77 Million | -1.31 Million | -413.91 Million | -1.16 Million |
| Common Stock Repurchased | 420.76 Million | -420.76 Million | - | - | - | 98.05 Million |
| Common Stock Issuance | -53.07 Million | 53.07 Million | - | 82.85 Million | 82.85 Million | -65.96 Million |
| Other Financing Activities | -14.14 Million | 16.85 Million | -23.73 Million | -58.01 Million | -89.82 Million | 62.94 Million |
| Accounts receivables | - | - | - | 736.48 Million | 736.48 Million | -362.16 Million |
| Accounts payables | - | - | - | - | -1.34 Billion | - |
| Inventory | - | - | - | 103.78 Million | 103.78 Million | -117 Million |
| Other working capital | - | - | - | 122.8 Million | -583.45 Million | - |
| Cash at beginning of period | 3.25 Billion | 4.46 Billion | 3.55 Billion | 5.09 Billion | 5.13 Billion | 5 Billion |
| Cash at end of period | 2.58 Billion | 4.46 Billion | 4.46 Billion | 3.55 Billion | 3.55 Billion | 5.09 Billion |
| Capital Expenditure | -168.07 Million | -86.91 Million | -109.14 Million | -290.56 Million | -1.23 Billion | -423.33 Million |
| Effect of forex changes on cash | -1.98 Million | 8.96 Million | 12.78 Million | -37.34 Million | 32.82 Million | -30.25 Million |
| Net cash flow / Change in cash | -666.4 Million | 3.22 Million | 909.14 Million | -1.53 Billion | -1.57 Billion | 88.32 Million |
| Free Cash Flow | -193.53 Million | -60.21 Million | -176.74 Million | -63.92 Million | -827.61 Million | -247.34 Million |
MGYR
3366
AX-UN
BAFNAPH
TND
KCP